ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance

Journal of Lipid Research

Volumn 42, Issue 2, 2001, Pages 241-248

  Escola Gil J C ^a   Julve, J ^a   Marzal Casacuberta, A ^a   Ordonez Llanos J ^a   Gonzalez Sastre F ^a   Blanco Vaca, F ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Atherosclerosis; Cholesteryl ester transfer protein; Familial combined hyperlipidemia; High density lipoprotein; Hypertrygliceridemia; Very low density lipoprotein

Indexed keywords

APOLIPOPROTEIN A2; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; FAT INTAKE; FEMALE; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; APOLIPOPROTEIN A-II; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHROMATOGRAPHY, LIQUID; FEMALE; GLYCOPROTEINS; HUMANS; LIPOPROTEINS, VLDL; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE;

EID: 0035091953     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Mouse models of atherosclerosis
2. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II
3. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice
4. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II
5. Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: Evidence of a potentially relevant species-specific interaction with diet
6. Free cholesterol deposition in the cornea of human apolipoprotein A-II transgenic mice with functional lecithin: Cholesterol acyltransferase deficiency
7. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia
8. Plasma cholesteryl ester transfer protein
9. Increased coronary heart disease in Japanese-American men with mutations in the cholesteryl ester transfer protein gene despite increased HDL
10. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan
11. Reduced high density lipoprotein cholesterol in human Cholesteryl ester transfer protein transgenic mice
12. The role of cholesteryl ester transfer protein in primate apolipoprotein A-1 metabolism-insights from studies with transgenic mice
13. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein
14. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein
15. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice
16. Pitfalls of direct HDL-cholesterol measurements in mouse models of hyperlipidemia and atherosclerosis
17. Marathon runners presented lower serum cholesteryl ester transfer protein activity than sedentary subjects
18. Lipoprotein lipase and hepatic lipase activities are differentially regulated in isolated hepatocytes from neonatal rats
19. Cholesteryl ester transfer activity in lipoprotein lipase deficiency and other primary hypertriglyceridemias
20. Isolation, characterization, and assay of plasma lipid transfer proteins
21. In the absence of the low density lipoprotein receptor, human apolipoprotein CI overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway
22. ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice
23. Evidence for linkage of the apolipoprotein A-II locus to plasma apolipoprotein A-II and free fatty acid levels in mice and humans
24. Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysis
25. SERBP-1 binds to multiple sites and transactivates the human apoA-II promotor in vitro
26. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor
27. Retinoids increase human apolipoprotein A-II expression through activation of the retinoid X receptor but not the retinoic acid receptor
28. Cooperative binding of upstream stimulatory factor and hepatic nuclear factor 4 drives the transcription of the human apolipoprotein A-II gene
29. Peroxisome proliferator-activated receptor mediates the adaptive response to fasting
30. Sterol regulatory element-binding proteins: Activators of cholesterol and fatty acid biosynthesis
31. Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I
32. Targeted disruption of the mouse lecithin:cholesterol acyltransferase (LCAT) gene
33. Human apoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice
34. The influence of apolipoproteins on the hepatic lipase-mediated hydrolysis of high density lipoprotein phospholipid and triacylglycerol
35. Differential interaction of the human cholesteryl ester transfer protein with plasma high density lipoproteins (HDLs) from humans, control mice, and transgenic mice to human HDL apolipoproteins
36. The regulation of hepatic triglyceride metabolism by free fatty acids
37. A mouse model with features of familial combined hyperlipidemia
38. Increased atherosclerosis in apoE and LDL receptor gene knockout mice as a result of human cholesteryl ester transfer protein transgene expression
39. ApoB metabolism in the cynomolgus monkey: Evidence for post-transcriptional regulation
40. Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apoA-II knock-out mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility
41. Novel genes for familial combined hyperlipidemia
42. Sterol upregulation of the human CETP expression in vitro and in transgenic mice by an LXR element
43. Relation between cholesterol ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia
44. Plasma concentations of cholesteryl ester transfer protein in hyperlipoproteinemia